Now showing items 1-10 of 28
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| Case report: tick-borne encephalitis (TBE) in a Belgian traveller returning from Germany | Gils, S.; Frans, J.; Ho, E.; Smismans, A.; Vermylen, P.; Dewil, M.; Dejaegher, L.; Heyndrickx, L.; Ariën, K. K.; Van Esbroeck, M. | Journal of Travel Medicine | 2018 | Letter |
| Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study [letter] | Decroo, T.; Van Deun, A.; Lynen, L. | Journal of Antimicrobial Chemotherapy | 2018 | Letter |
| Should gatifloxacin be included in the model list of essential medicines? [letter] | Chiang, C. Y.; Trebucq, A.; Piubello, A.; Rieder, H. L.; Van Deun, A. | European Respiratory Journal | 2018 | Letter |
| Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe [correspondence] | Heldal, E.; Van Deun, A.; Chiang, C. Y.; Rieder, H. L. | European Respiratory Journal | 2017 | Letter |
| The HIV-1 transmission bottleneck [letter] | Kariuki, S. M.; Selhorst, P.; Ariën, K. K.; Dorfman, J. R. | Retrovirology | 2017 | Letter |
| High mortality in non-Ebola virus disease cases: need to provide timely and effective care [letter] | Colebunders, R.; Jacob, S. T.; Ariën, K. K.; De Weggheleire, A.; Decroo, T. | Lancet Infectious Diseases | 2017 | Letter |
| Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis | Rieder, H. L.; Van Deun, A. | International Journal of Tuberculosis and Lung Disease | 2017 | Letter |
| Read the new microscopy handbook: even the Ziehl-Neelsen technique has changed [letter] | Angra, P.; Ridderhof, J.; Tahseen, S.; Van Deun, A. | International Journal of Tuberculosis and Lung Disease | 2016 | Article |
| Treatment of visceral leishmaniasis: pitfalls and stewardship [letter] | Dorlo, T. P. C.; Ostyn, B. A.; Uranw, S.; Dujardin, J. C.; Boelaert, M. | Lancet Infectious Diseases | 2016 | Letter |
| Overlooking the importance of immunoassays [authors' reply] | Cnops, L.; Van Griensven, J.; Honko, A. N.; Bausch, D. G.; Sprecher, A.; Hill, C. E.; Colebunders, R.; Johnson, J. C.; Griffiths, A.; Palacios, G. F.; Kraft, C. S.; Kobinger, G.; Hewlett, A.; Norwood, D. A.; Sabeti, P.; Jahrling, P. B.; Formenty, P.; Kuhn, J. H.; Ariën, K. | Lancet Infectious Diseases | 2016 | Letter |
Now showing items 1-10 of 28